Michael John Sumner

Insider Reports History

Entity
Individual
Location
660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA
Signature
/s/ Michael John Sumner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael John Sumner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
INOVIO PHARMACEUTICALS, INC. Chief Medical Officer Common Stock 8.22K $107K $13.07 Jun 30, 2024 Direct
INOVIO PHARMACEUTICALS, INC. Chief Medical Officer Restricted Stock Unit 2.92K $38.1K $13.07 Jun 30, 2024 Direct
INOVIO PHARMACEUTICALS, INC. Chief Medical Officer Common Stock Option 18.8K Feb 28, 2024 Direct

Insider Reports Filed by Michael John Sumner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INO INOVIO PHARMACEUTICALS, INC. Jun 30, 2024 2 $0 4 Jul 1, 2024 Chief Medical Officer
INO INOVIO PHARMACEUTICALS, INC. May 15, 2024 2 $0 4 May 16, 2024 Chief Medical Officer
INO INOVIO PHARMACEUTICALS, INC. Feb 28, 2024 2 $0 4 Feb 28, 2024 Chief Medical Officer
INO INOVIO PHARMACEUTICALS, INC. Jun 30, 2023 2 $0 4 Jul 3, 2023 Chief Medical Officer
INO INOVIO PHARMACEUTICALS, INC. May 15, 2023 1 $0 4 May 17, 2023 Chief Medical Officer
INO INOVIO PHARMACEUTICALS, INC. Feb 27, 2023 1 $0 4 Feb 28, 2023 Chief Medical Officer
INO INOVIO PHARMACEUTICALS, INC. Jun 30, 2022 2 $0 4 Jul 6, 2022 Chief Medical Officer
INO INOVIO PHARMACEUTICALS, INC. Jun 27, 2022 0 $0 3 Jul 6, 2022 Chief Medical Officer